Patterns and Predictors of Blood–Brain Barrier Permeability Derangements in Acute Ischemic Stroke
暂无分享,去创建一个
Jeffry R Alger | David S Liebeskind | Jeffrey L Saver | J. Alger | D. Liebeskind | S. Starkman | J. Saver | B. Ovbiagele | O. Bang | Samir H. Shah | Sidney Starkman | Bruce Ovbiagele | Oh Young Bang | B. Buck | Brian H Buck | Samir H Shah
[1] T. Neumann-Haefelin,et al. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. , 2006, Stroke.
[2] Steven Warach,et al. Early blood–brain barrier disruption in human focal brain ischemia , 2004, Annals of neurology.
[3] R. Higashida,et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke , 2001, Neurology.
[4] A. Sorensen,et al. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. , 2002, AJR. American journal of roentgenology.
[5] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.
[6] W. Hacke,et al. Hemorrhagic Transformation of Ischemic Brain Tissue: Asymptomatic or Symptomatic? , 2001, Stroke.
[7] T. N. t-P. S. S. Group,et al. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. , 1997, Stroke.
[8] Ims Study Investigators. Hemorrhage in the Interventional Management of Stroke Study , 2006, Stroke.
[9] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[10] Jeffry R Alger,et al. Prediction of hemorrhagic transformation after recanalization therapy using T2*‐permeability magnetic resonance imaging , 2007, Annals of neurology.
[11] A. Demchuk,et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. , 1999, Stroke.
[12] W P Dillon,et al. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. , 2001, Academic radiology.
[13] Dong Gyu Na,et al. Prediction of hemorrhagic transformation in acute ischemic stroke: role of diffusion-weighted imaging and early parenchymal enhancement. , 2005, AJNR. American journal of neuroradiology.
[14] V Larrue,et al. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. , 1997, Stroke.
[15] Werner Hacke,et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study , 2006, The Lancet Neurology.
[16] Jeffry R Alger,et al. Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue , 2003, Stroke.
[17] Erich Bluhmki,et al. Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Secondary Analysis of the European-Australasian Acute Stroke Study (ECASS II) , 2001, Stroke.
[18] B. Rosen,et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis , 1996, Magnetic resonance in medicine.
[19] G. Schlaug,et al. Markedly Reduced Apparent Blood Volume on Bolus Contrast Magnetic Resonance Imaging as a Predictor of Hemorrhage After Thrombolytic Therapy for Acute Ischemic Stroke , 2005, Stroke.
[20] R. Bammer,et al. Risk Factors of Symptomatic Intracerebral Hemorrhage After tPA Therapy for Acute Stroke , 2007, Stroke.
[21] Gottfried Schlaug,et al. Predictors of Hemorrhagic Transformation After Intravenous Recombinant Tissue Plasminogen Activator: Prognostic Value of the Initial Apparent Diffusion Coefficient and Diffusion-Weighted Lesion Volume , 2002, Stroke.
[22] Andrea Kassner,et al. Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. , 2005, AJNR. American journal of neuroradiology.
[23] G Johnson,et al. Comparison of microvascular permeability measurements, K(trans), determined with conventional steady-state T1-weighted and first-pass T2*-weighted MR imaging methods in gliomas and meningiomas. , 2006, AJNR. American journal of neuroradiology.
[24] J. Babb,et al. Measuring Elevated Microvascular Permeability and Predicting Hemorrhagic Transformation in Acute Ischemic Stroke Using First-Pass Dynamic Perfusion CT Imaging , 2007, American Journal of Neuroradiology.
[25] Scott Hamilton,et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study , 2006, Annals of neurology.
[26] D. Kent,et al. Are Some Patients Likely to Benefit From Recombinant Tissue-Type Plasminogen Activator for Acute Ischemic Stroke Even Beyond 3 Hours From Symptom Onset? , 2003, Stroke.